Chapter/Section Purchase

1 Artificial Lung Devices Market Overview
1.1 Product Overview and Scope of Artificial Lung Devices
1.2 Artificial Lung Devices Segment by Type
1.2.1 Global Artificial Lung Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Venovenous (VV) Artificial Lung Devices
1.2.3 Venoarterial (VA) Artificial Lung Devices
1.3 Artificial Lung Devices Segment by Application
1.3.1 Global Artificial Lung Devices Sales Comparison by Application: (2022-2028)
1.3.2 Pediatric
1.3.3 Adult
1.4 Global Artificial Lung Devices Market Size Estimates and Forecasts
1.4.1 Global Artificial Lung Devices Revenue 2017-2028
1.4.2 Global Artificial Lung Devices Sales 2017-2028
1.4.3 Artificial Lung Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Artificial Lung Devices Market Competition by Manufacturers
2.1 Global Artificial Lung Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Artificial Lung Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Artificial Lung Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Artificial Lung Devices Manufacturing Sites, Area Served, Product Type
2.5 Artificial Lung Devices Market Competitive Situation and Trends
2.5.1 Artificial Lung Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Artificial Lung Devices Players Market Share by Revenue
2.5.3 Global Artificial Lung Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Lung Devices Retrospective Market Scenario by Region
3.1 Global Artificial Lung Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Artificial Lung Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Artificial Lung Devices Market Facts & Figures by Country
3.3.1 North America Artificial Lung Devices Sales by Country
3.3.2 North America Artificial Lung Devices Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Artificial Lung Devices Market Facts & Figures by Country
3.4.1 Europe Artificial Lung Devices Sales by Country
3.4.2 Europe Artificial Lung Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Artificial Lung Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Artificial Lung Devices Sales by Region
3.5.2 Asia Pacific Artificial Lung Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Artificial Lung Devices Market Facts & Figures by Country
3.6.1 Latin America Artificial Lung Devices Sales by Country
3.6.2 Latin America Artificial Lung Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Artificial Lung Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Artificial Lung Devices Sales by Country
3.7.2 Middle East and Africa Artificial Lung Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Artificial Lung Devices Historic Market Analysis by Type
4.1 Global Artificial Lung Devices Sales Market Share by Type (2017-2022)
4.2 Global Artificial Lung Devices Revenue Market Share by Type (2017-2022)
4.3 Global Artificial Lung Devices Price by Type (2017-2022)
5 Global Artificial Lung Devices Historic Market Analysis by Application
5.1 Global Artificial Lung Devices Sales Market Share by Application (2017-2022)
5.2 Global Artificial Lung Devices Revenue Market Share by Application (2017-2022)
5.3 Global Artificial Lung Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Abiomed
6.1.1 Abiomed Corporation Information
6.1.2 Abiomed Description and Business Overview
6.1.3 Abiomed Artificial Lung Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Abiomed Artificial Lung Devices Product Portfolio
6.1.5 Abiomed Recent Developments/Updates
6.2 MC3 Cardiopulmonary
6.2.1 MC3 Cardiopulmonary Corporation Information
6.2.2 MC3 Cardiopulmonary Description and Business Overview
6.2.3 MC3 Cardiopulmonary Artificial Lung Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 MC3 Cardiopulmonary Artificial Lung Devices Product Portfolio
6.2.5 MC3 Cardiopulmonary Recent Developments/Updates
6.3 ALung Technologies Inc.
6.3.1 ALung Technologies Inc. Corporation Information
6.3.2 ALung Technologies Inc. Description and Business Overview
6.3.3 ALung Technologies Inc. Artificial Lung Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 ALung Technologies Inc. Artificial Lung Devices Product Portfolio
6.3.5 ALung Technologies Inc. Recent Developments/Updates
6.4 United Therapeutics Corporation
6.4.1 United Therapeutics Corporation Corporation Information
6.4.2 United Therapeutics Corporation Description and Business Overview
6.4.3 United Therapeutics Corporation Artificial Lung Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 United Therapeutics Corporation Artificial Lung Devices Product Portfolio
6.4.5 United Therapeutics Corporation Recent Developments/Updates
6.5 XVIVO Perfusion
6.5.1 XVIVO Perfusion Corporation Information
6.5.2 XVIVO Perfusion Description and Business Overview
6.5.3 XVIVO Perfusion Artificial Lung Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 XVIVO Perfusion Artificial Lung Devices Product Portfolio
6.5.5 XVIVO Perfusion Recent Developments/Updates
6.6 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Artificial Lung Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Medtronic Artificial Lung Devices Product Portfolio
6.6.5 Medtronic Recent Developments/Updates
6.7 Getinge
6.6.1 Getinge Corporation Information
6.6.2 Getinge Description and Business Overview
6.6.3 Getinge Artificial Lung Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Getinge Artificial Lung Devices Product Portfolio
6.7.5 Getinge Recent Developments/Updates
6.8 Xenios AG
6.8.1 Xenios AG Corporation Information
6.8.2 Xenios AG Description and Business Overview
6.8.3 Xenios AG Artificial Lung Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Xenios AG Artificial Lung Devices Product Portfolio
6.8.5 Xenios AG Recent Developments/Updates
7 Artificial Lung Devices Manufacturing Cost Analysis
7.1 Artificial Lung Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Artificial Lung Devices
7.4 Artificial Lung Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Artificial Lung Devices Distributors List
8.3 Artificial Lung Devices Customers
9 Artificial Lung Devices Market Dynamics
9.1 Artificial Lung Devices Industry Trends
9.2 Artificial Lung Devices Market Drivers
9.3 Artificial Lung Devices Market Challenges
9.4 Artificial Lung Devices Market Restraints
10 Global Market Forecast
10.1 Artificial Lung Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Artificial Lung Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Artificial Lung Devices by Type (2023-2028)
10.2 Artificial Lung Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Artificial Lung Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Artificial Lung Devices by Application (2023-2028)
10.3 Artificial Lung Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Artificial Lung Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Artificial Lung Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer